ZCMD
Zhongchao Inc.
Price Chart
Latest Quote
$0.03
-0.01 (-28.18%)
Current Price
| Previous Close | $0.04 |
| Open | $0.03 |
| Day High | $0.03 |
| Day Low | $0.02 |
| Volume | 137,277,085 |
Stock Information
| Shares Outstanding | 127K |
| Total Debt | $26K |
| Cash Equivalents | $13.92M |
| Revenue | $11.37M |
| Net Income | $-6.31M |
| Sector | Healthcare |
| Industry | Health Information Services |
| Market Cap | $20K |
| EPS (TTM) | $-1.85 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $-9.83M |
| Sales | $11.37M |
| Income | $-6.31M |
| Book/sh | $6.39 |
| Cash/sh | $110.05 |
| Employees | 33 |
Financial Ratios
| Quick Ratio | 11.01 |
| Current Ratio | 11.11 |
| Debt/Eq | 0.12 |
Returns & Margins
| ROA | -15.47% |
| ROE | -24.88% |
| Gross Margin | 45.03% |
| Operating Margin | -92.00% |
| Profit Margin | -55.47% |
Ownership
| Insider Ownership | 0.43% |
| Institutional Ownership | 0.37% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 0.00 |
| P/B | 0.00 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $1.03 |
| SMA50 | $1.62 |
| SMA200 | $4.15 |
| RSI | 14.04 |
| ATR | 0.2223 |
| Shares Float | 2.39M |
| Short Float | 2.54% |
| Short Ratio | 7.51 |
| Volatility | -0.15 |
| Rel Volume | 2.50 |
Performance History
| Week | -84.43% |
| Month | -98.83% |
| Quarter | -98.40% |
| 6 Months | -99.46% |
| YTD | -99.33% |
| Year | -99.71% |
| 3 Years | -99.97% |
| 5 Years | -99.98% |
| 10 Years | -99.99% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-05 | $0.03 | 137,277,085 |
| 2026-06-04 | $0.04 | 162,043,800 |
| 2026-06-03 | $0.05 | 269,673,200 |
| 2026-06-02 | $0.05 | 165,858,000 |
| 2026-06-01 | $0.08 | 199,508,800 |
| 2026-05-29 | $0.17 | 163,767,600 |
| 2026-05-28 | $0.54 | 1,946,500 |
| 2026-05-27 | $1.55 | 5,600 |
| 2026-05-26 | $1.45 | 16,400 |
| 2026-05-22 | $1.43 | 11,100 |
| 2026-05-21 | $1.49 | 13,300 |
| 2026-05-20 | $1.58 | 1,800 |
| 2026-05-19 | $1.56 | 9,600 |
| 2026-05-18 | $1.60 | 8,100 |
| 2026-05-15 | $1.46 | 37,500 |
| 2026-05-14 | $1.45 | 8,000 |
| 2026-05-13 | $1.49 | 31,600 |
| 2026-05-12 | $1.46 | 15,000 |
| 2026-05-11 | $1.52 | 12,900 |
| 2026-05-08 | $1.58 | 32,500 |
| 2026-05-07 | $2.13 | 43,200 |
| 2026-05-06 | $2.22 | 6,100 |
About Zhongchao Inc.
Zhongchao Inc. provides healthcare information, education, and training services to healthcare professionals under their MDMOOC brand in the People's Republic of China. It operates through two segments, MDMOOC services, and Sales of Patented Drugs. The company offers patient management services in the tumor and rare diseases field, internet healthcare services, and pharmaceutical services, and operates an online information platform. It also provides online and onsite health information services, healthcare education programs, and healthcare training products, including clinical practice training, open classes on popular medical topics, interactive case studies, academic conferences and workshops, continuing education courses, and articles and short videos with educational healthcare content. The company offers its services through its MDMOOC online platform, such as the MDMOOC mobile app, MOOC Medical WeChat subscription account, and MDMOOC website, and patient management services through an IT system under the Zhongxun brand, WeChat mini program, and Zhongxin Health WeChat mini program. It serves pharmaceutical enterprises and non-profit organizations, including medical associations, medical institutions, medical journals, medical foundations, and hospitals, as well as healthcare professionals, nurses, and doctors. Zhongchao Inc. was founded in 2012 and is headquartered in Shanghai, China.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $6,253,455 | $6,952,560 | $10,921,753 | $7,794,852 |
| Cost Of Revenue | $6,253,455 | $6,952,560 | $10,921,753 | $7,794,852 |
| Total Revenue | $11,374,996 | $15,864,773 | $19,433,945 | $14,151,516 |
| Operating Revenue | $11,374,996 | $15,864,773 | $19,433,945 | $14,109,185 |
| Expenses | ||||
| Total Expenses | $17,566,221 | $16,206,040 | $24,844,230 | $17,105,978 |
| Other Income Expense | $79,412 | $160,015 | $-6,803,768 | $262,442 |
| Other Non Operating Income Expenses | $79,412 | $160,015 | $1,069,745 | $262,442 |
| Net Non Operating Interest Income Expense | $343,128 | $243,008 | $237,054 | $142,014 |
| Operating Expense | $11,312,766 | $9,253,480 | $13,922,477 | $9,311,126 |
| Selling And Marketing Expense | $1,490,594 | $4,010,382 | $6,710,757 | $2,099,968 |
| General And Administrative Expense | $9,814,087 | $4,990,647 | $6,697,309 | $6,799,634 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-6,310,153 | $-643,229 | $-11,335,911 | $-2,940,891 |
| Net Interest Income | $343,128 | $243,008 | $237,054 | $142,014 |
| Interest Income | $343,128 | $243,008 | $237,054 | $142,014 |
| Normalized Income | $-6,310,153 | $-643,229 | $-3,902,527 | $-2,940,891 |
| Net Income From Continuing And Discontinued Operation | $-6,310,153 | $-643,229 | $-11,335,911 | $-2,940,891 |
| Total Operating Income As Reported | $-6,191,225 | $-341,267 | $-13,283,798 | $-2,954,462 |
| Net Income Common Stockholders | $-6,310,153 | $-643,229 | $-11,335,911 | $-2,940,891 |
| Net Income | $-6,310,153 | $-643,229 | $-11,335,911 | $-2,940,891 |
| Net Income Including Noncontrolling Interests | $-5,814,867 | $-273,413 | $-11,307,239 | $-2,822,319 |
| Net Income Continuous Operations | $-5,814,867 | $-273,413 | $-11,307,239 | $-2,822,319 |
| Pretax Income | $-5,768,685 | $61,756 | $-11,976,999 | $-2,550,006 |
| Special Income Charges | $0 | $0 | $-7,873,513 | $0 |
| Interest Income Non Operating | $343,128 | $243,008 | $237,054 | $142,014 |
| Operating Income | $-6,191,225 | $-341,267 | $-5,410,285 | $-2,954,462 |
| Gross Profit | $5,121,541 | $8,912,213 | $8,512,192 | $6,356,664 |
| Per Share | ||||
| Diluted EPS | - | $-0.99 | $-34.83 | $-9.05 |
| Basic EPS | - | $-0.99 | $-34.83 | $-9.05 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $-440,129 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-5,869,558 | $87,088 | $3,386,842 | $-2,224,151 |
| Total Unusual Items | $0 | $0 | $-7,873,513 | $0 |
| Total Unusual Items Excluding Goodwill | $0 | $0 | $-7,873,513 | $0 |
| Reconciled Depreciation | $321,667 | $428,355 | $923,614 | $730,311 |
| EBITDA (Bullshit earnings) | $-5,869,558 | $87,088 | $-4,486,671 | $-2,224,151 |
| EBIT | $-6,191,225 | $-341,267 | $-5,410,285 | $-2,954,462 |
| Diluted NI Availto Com Stockholders | $-6,310,153 | $-643,229 | $-11,335,911 | $-2,940,891 |
| Minority Interests | $-495,286 | $-369,816 | $-28,672 | $-118,572 |
| Tax Provision | $46,182 | $335,169 | $-669,760 | $272,313 |
| Gain On Sale Of Ppe | $0 | $0 | $-1,719,442 | $0 |
| Impairment Of Capital Assets | $0 | $0 | $6,154,071 | $0 |
| Research And Development | $8,085 | $252,451 | $514,411 | $411,524 |
| Selling General And Administration | $11,304,681 | $9,001,029 | $13,408,066 | $8,899,602 |
| Other Gand A | $9,814,087 | $4,990,647 | $6,697,309 | $6,799,634 |
| Diluted Average Shares | - | $650,678 | $325,419 | $324,972 |
| Basic Average Shares | - | $650,678 | $325,419 | $324,972 |
Fetched: 2026-06-02
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $18,623,072 | $20,825,730 | $17,989,242 | $22,943,877 |
| Total Assets | $24,146,846 | $25,884,953 | $24,416,643 | $38,614,345 |
| Total Non Current Assets | $7,184,720 | $7,177,736 | $5,705,597 | $15,910,185 |
| Non Current Deferred Assets | $44,194 | $119,425 | $357,878 | $1,864,729 |
| Non Current Deferred Taxes Assets | $44,194 | $119,425 | $357,878 | $1,864,729 |
| Goodwill And Other Intangible Assets | $7,614 | $12,177 | $17,539 | $6,984,345 |
| Other Intangible Assets | $7,614 | $12,177 | $17,539 | $1,216,841 |
| Current Assets | $16,962,126 | $18,707,217 | $18,711,046 | $22,704,160 |
| Other Current Assets | $127,130 | $142,423 | $153,186 | $70,400 |
| Prepaid Assets | $30,372 | $114,391 | $1,503,206 | $1,272,172 |
| Inventory | $0 | $586,221 | $592,382 | $189,106 |
| Receivables | $2,881,992 | $4,780,435 | $3,015,769 | $9,133,613 |
| Accrued Interest Receivable | $99,299 | $98,115 | $181,337 | $88,720 |
| Accounts Receivable | $2,782,693 | $4,682,320 | $2,552,738 | $6,772,988 |
| Allowance For Doubtful Accounts Receivable | $-556,051 | $-66,093 | $-2,197 | $-207,269 |
| Gross Accounts Receivable | $3,338,744 | $4,748,413 | $2,554,935 | $6,980,257 |
| Cash Cash Equivalents And Short Term Investments | $13,922,632 | $13,083,747 | $13,446,503 | $12,038,869 |
| Cash And Cash Equivalents | $8,098,075 | $7,841,306 | $7,548,694 | $11,520,453 |
| Investmentin Financial Assets | - | $0 | $165,871 | $84,606 |
| Loans Receivable | - | $0 | $281,694 | $1,840,000 |
| Receivables Adjustments Allowances | - | - | - | $-207,269 |
| Other Receivables | - | - | - | $205,726 |
| Current Deferred Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $26,083 | $57,517 | $808,156 | $1,702,478 |
| Long Term Debt And Capital Lease Obligation | $0 | $23,832 | $571,862 | $1,221,845 |
| Current Debt And Capital Lease Obligation | $26,083 | $33,685 | $236,294 | $480,633 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $1,548,890 | $1,733,900 | $3,378,473 | $5,595,080 |
| Total Non Current Liabilities Net Minority Interest | $22,260 | $203,470 | $700,112 | $1,430,045 |
| Non Current Deferred Liabilities | $22,260 | $179,638 | $128,250 | $208,200 |
| Non Current Deferred Taxes Liabilities | $22,260 | $179,638 | $128,250 | $208,200 |
| Current Liabilities | $1,526,630 | $1,530,430 | $2,678,361 | $4,165,035 |
| Other Current Liabilities | $66,127 | $112,237 | $50,743 | $95,595 |
| Current Deferred Liabilities | $150,009 | $203,787 | $838,838 | $395,263 |
| Payables And Accrued Expenses | $1,284,411 | $1,180,721 | $1,552,486 | $3,193,544 |
| Payables | $1,075,220 | $981,303 | $1,324,602 | $2,896,678 |
| Other Payable | $384,945 | $200,228 | $498,185 | $83,367 |
| Total Tax Payable | $164,177 | $246,002 | $142,480 | $2,672,477 |
| Accounts Payable | $526,098 | $535,073 | $683,937 | $140,834 |
| Income Tax Payable | - | $0 | $6,734 | $2,292,765 |
| Equity | ||||
| Common Stock Equity | $18,630,686 | $20,837,907 | $18,006,781 | $29,928,222 |
| Total Equity Gross Minority Interest | $22,597,956 | $24,151,053 | $21,038,170 | $33,019,265 |
| Stockholders Equity | $18,630,686 | $20,837,907 | $18,006,781 | $29,928,222 |
| Other Equity Interest | $-1,716,667 | - | - | - |
| Gains Losses Not Affecting Retained Earnings | $31,467 | $-287,270 | $138,267 | $803,193 |
| Other Equity Adjustments | $31,467 | $-287,270 | $138,267 | $803,193 |
| Retained Earnings | $-14,190,570 | $-7,959,276 | $-7,268,025 | $4,124,037 |
| Long Term Equity Investment | - | $1,089,960 | $1,145,404 | $1,179,300 |
| Investments In Other Ventures Under Equity Method | - | - | - | $1,179,300 |
| Other | ||||
| Ordinary Shares Number | $3,844,237 | $3,156,737 | $308,713 | $308,488 |
| Share Issued | $3,844,237 | $3,156,737 | $308,713 | $308,488 |
| Tangible Book Value | $18,623,072 | $20,825,730 | $17,989,242 | $22,943,877 |
| Invested Capital | $18,630,686 | $20,837,907 | $18,006,781 | $29,928,222 |
| Working Capital | $15,435,496 | $17,176,787 | $16,032,685 | $18,539,125 |
| Capital Lease Obligations | $26,083 | $57,517 | $808,156 | $1,702,478 |
| Total Capitalization | $18,630,686 | $20,837,907 | $18,006,781 | $29,928,222 |
| Minority Interest | $3,967,270 | $3,313,146 | $3,031,389 | $3,091,043 |
| Additional Paid In Capital | $34,475,566 | $29,059,063 | $25,133,933 | $24,998,388 |
| Capital Stock | $30,890 | $25,390 | $2,606 | $2,604 |
| Common Stock | $30,890 | $25,390 | $2,606 | $2,604 |
| Long Term Capital Lease Obligation | $0 | $23,832 | $571,862 | $1,221,845 |
| Current Deferred Revenue | $150,009 | $203,787 | $838,838 | $395,263 |
| Current Capital Lease Obligation | $26,083 | $33,685 | $236,294 | $480,633 |
| Current Accrued Expenses | $209,191 | $199,418 | $227,884 | $296,866 |
| Investments And Advances | $1,230,635 | $1,089,960 | $1,311,275 | $1,263,906 |
| Net PPE | $5,902,277 | $5,956,174 | $4,018,905 | $5,797,205 |
| Accumulated Depreciation | $-675,729 | $-400,633 | $-196,581 | $-379,879 |
| Gross PPE | $6,578,006 | $6,356,807 | $4,215,486 | $6,177,084 |
| Leases | $0 | $50,320 | $51,732 | $53,253 |
| Other Properties | $25,053 | $89,020 | - | $1,666,777 |
| Machinery Furniture Equipment | $15,334 | $8,409 | $18,287 | $111,617 |
| Land And Improvements | $6,537,619 | $6,209,058 | $3,348,814 | $4,105,956 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $5,824,557 | $5,242,441 | $5,897,809 | $518,416 |
| Buildings And Improvements | - | $89,020 | $796,653 | $1,666,777 |
| Available For Sale Securities | - | - | $165,871 | $84,606 |
| Goodwill | - | - | $0 | $5,767,504 |
| Construction In Progress | - | - | $0 | $239,481 |
| Duefrom Related Parties Current | - | - | $0 | $226,179 |
Fetched: 2026-06-02
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $692,830 | $-4,518,426 | $-785,507 | $-2,523,112 |
| Operating Activities | ||||
| Operating Cash Flow | $845,391 | $-1,473,243 | $54,229 | $-661,740 |
| Cash Flow From Continuing Operating Activities | $845,391 | $-1,473,243 | $54,229 | $-661,740 |
| Operating Gains Losses | $31,571 | $-3,933 | $1,607,042 | $-96,841 |
| Investing Activities | ||||
| Capital Expenditure | $-152,561 | $-3,045,183 | $-839,736 | $-1,861,372 |
| Investing Cash Flow | $-826,599 | $-1,807,753 | $-3,754,655 | $-3,346,658 |
| Cash Flow From Continuing Investing Activities | $-826,599 | $-1,807,753 | $-3,754,655 | $-3,346,658 |
| Net Other Investing Changes | - | $277,944 | $1,777,860 | $914,247 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $0 | $3,838,200 | $0 | $1,850,744 |
| Financing Cash Flow | $0 | $3,838,200 | $0 | $1,850,744 |
| Cash Flow From Continuing Financing Activities | $0 | $3,838,200 | $0 | $1,850,744 |
| Net Common Stock Issuance | $0 | $3,838,200 | $0 | $1,850,744 |
| Common Stock Issuance | $0 | $3,838,200 | $0 | $1,850,744 |
| Other | ||||
| Income Tax Paid Supplemental Data | $126,589 | $45,944 | $114,501 | $134,232 |
| End Cash Position | $8,098,075 | $7,841,306 | $7,548,694 | $11,520,453 |
| Beginning Cash Position | $7,841,306 | $7,548,694 | $11,520,453 | $13,914,982 |
| Effect Of Exchange Rate Changes | $237,977 | $-264,592 | $-271,333 | $-236,875 |
| Changes In Cash | $18,792 | $557,204 | $-3,700,426 | $-2,157,654 |
| Net Investment Purchase And Sale | $-674,038 | $959,486 | $-4,724,413 | $-462,747 |
| Sale Of Investment | $8,805,726 | $11,616,216 | $1,592,844 | $533,891 |
| Purchase Of Investment | $-9,479,764 | $-10,656,730 | $-6,317,257 | $-996,638 |
| Net PPE Purchase And Sale | $-152,561 | $-3,045,183 | $-808,102 | $-748,932 |
| Sale Of PPE | $0 | $0 | $31,634 | $1,112,440 |
| Purchase Of PPE | $-152,561 | $-3,045,183 | $-839,736 | $-1,861,372 |
| Change In Working Capital | $1,818,411 | $-1,998,312 | $2,687,494 | $172,877 |
| Change In Other Working Capital | $-61,004 | $-620,949 | $456,078 | $369,249 |
| Change In Other Current Liabilities | $1,512 | $-240,551 | $-428,363 | $-306,392 |
| Change In Other Current Assets | $47,650 | $164,354 | $27,685 | $66,148 |
| Change In Payables And Accrued Expense | $1,638 | $-259,808 | $527,819 | $-60,203 |
| Change In Accrued Expense | $33,166 | $-127,754 | $81,554 | $-167,585 |
| Change In Payable | $-31,528 | $-132,054 | $446,265 | $107,382 |
| Change In Account Payable | $-31,528 | $-132,054 | $548,591 | $103,825 |
| Change In Tax Payable | $0 | $0 | $-102,326 | $3,557 |
| Change In Income Tax Payable | $0 | $0 | $-102,326 | $3,557 |
| Change In Prepaid Assets | $59,394 | $1,285,433 | $-275,726 | $-778,384 |
| Change In Inventory | $595,340 | $-10,166 | $-409,771 | $-193,833 |
| Change In Receivables | $1,173,881 | $-2,316,625 | $2,789,772 | $1,076,292 |
| Changes In Account Receivables | $1,173,881 | $-2,316,625 | $2,789,772 | $1,076,292 |
| Stock Based Compensation | $3,705,336 | $109,714 | $135,547 | $160,777 |
| Unrealized Gain Loss On Investment Securities | $-8,078 | $-108,949 | $-654,980 | $240,489 |
| Provisionand Write Offof Assets | $873,841 | $85,644 | $1,247,907 | $753,447 |
| Asset Impairment Charge | $0 | $0 | $6,154,071 | $65,394 |
| Deferred Tax | $-82,490 | $287,651 | $-739,227 | $134,125 |
| Deferred Income Tax | $-82,490 | $287,651 | $-739,227 | $134,125 |
| Depreciation Amortization Depletion | $321,667 | $428,355 | $923,614 | $730,311 |
| Depreciation And Amortization | $321,667 | $428,355 | $923,614 | $730,311 |
| Amortization Cash Flow | $4,958 | $4,953 | $346,099 | $141,444 |
| Amortization Of Intangibles | $4,958 | $4,953 | $346,099 | $141,444 |
| Depreciation | $316,709 | $423,402 | $577,515 | $588,867 |
| Gain Loss On Investment Securities | $7,040 | $-4,796 | $-81,036 | - |
| Gain Loss On Sale Of PPE | $24,531 | $863 | $1,688,078 | $-96,921 |
| Net Income From Continuing Operations | $-5,814,867 | $-273,413 | $-11,307,239 | $-2,822,319 |
| Net Business Purchase And Sale | - | $0 | $0 | $-3,049,226 |
| Sale Of Business | - | $0 | $0 | $6,206 |
| Purchase Of Business | - | $0 | $0 | $-3,055,432 |
| Earnings Losses From Equity Investments | - | $24,502 | $229 | $80 |
| Interest Paid Supplemental Data | - | - | $0 | $0 |
| Repayment Of Debt | - | - | - | - |
| Net Issuance Payments Of Debt | - | - | - | - |
| Net Long Term Debt Issuance | - | - | - | - |
| Long Term Debt Payments | - | - | - | - |
Fetched: 2026-06-02